Microsonic Systems Inc.
has developed an acoustics-based micro-fluidics instrument
based on a novel, patented technology that will significantly
improve the accuracy and efficiency of drug identification. The
Company’s target markets are the pharmaceutical and laboratory
automation industries, although the Company believes there are
several other potential markets.
Our lateral ultrasonic thrust (LUT)™ technology, using
a micro-electro-mechanical systems (MEMS) based transducer,
creates bulk acoustic waves which are capable of mixing and
solubilizing bio-chemical reagents more rapidly and more
homogenously than existing technologies. Improving the speed
and reliability of mixing both increases the likelihood of the
positive identification of new drugs, and decreases the
likelihood of investing time and effort in unfruitful clinical
trials. Improving the speed and reliability of mixing can
decrease the time and cost required to bring new
pharmaceuticals to market.